Ausgabe 3/2018
Inhalt (27 Artikel)
Dietary supplements and fatigue in patients with breast cancer: a systematic review
Paula Tâmara Vieira Teixeira Pereira, Andréa Dias Reis, Renata Rodrigues Diniz, Franciléia Andrade Lima, Richard Diego Leite, Mayara Cristina Pinto da Silva, Rosane Nassar Meireles Guerra, Érica Brandão de Moraes Vieira, João Batista Santos Garcia
Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings
David S. Barreto, Emily L. Sedgwick, Chandandeep S. Nagi, Ana P. Benveniste
Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
Jiayu Wang, Binghe Xu, Wenna Wang, Xiaoyu Zhai, Xuelian Chen
Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence
Fernando A. Angarita, Maryam Elmi, Yimeng Zhang, Nicole J. Look Hong
Breast cancer and its impact in male transsexuals
Dejan Nikolić, Miroslav Granić, Nebojša Ivanović, Darko Zdravković, Aleksandra Nikolić, Violeta Stanimirović, Marija Zdravković, Srdjan Dikić, Marko Nikolić, Miroslav Djordjević
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment
Emanuel C. A. Bauer, Fabienne Schochter, Peter Widschwendter, Amelie DeGregorio, Ulrich Andergassen, Thomas W. P. Friedl, Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Matthias W. Beckmann, Klaus Pantel, Wolfgang Janni, Brigitte Rack, Christoph Scholz
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells
Audrey Berthe, Marie Zaffino, Claire Muller, François Foulquier, Marine Houdou, Céline Schulz, Frédéric Bost, Elia De Fay, Sabine Mazerbourg, Stéphane Flament
Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer
Nashwa Kabil, Recep Bayraktar, Nermin Kahraman, Hamada A. Mokhlis, George A. Calin, Gabriel Lopez-Berestein, Bulent Ozpolat
Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review
Andrew Robinson, Osama Souied, A. Brianne Bota, Nathalie Levasseur, Carol Stober, John Hilton, Dalia Kamel, Brian Hutton, Lisa Vandermeer, Sasha Mazzarello, Anil A. Joy, Dean Fergusson, Sheryl McDiarmid, Mathew McInnes, Risa Shorr, Mark Clemons
A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge
Kristin E. Rojas, Donna-Marie Manasseh, Peter L. Flom, Solomon Agbroko, Nicole Bilbro, Charusheela Andaz, Patrick I. Borgen
Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
M. Martín, J. C. de la Torre-Montero, S. López-Tarruella, K. Pinilla, A. Casado, S. Fernandez, Y. Jerez, J. Puente, I. Palomero, R. González del Val, M. del Monte-Millan, T. Massarrah, C. Vila, B. García-Paredes, J. A. García-Sáenz, A. Lluch
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
M. Martín, J. C. de la Torre-Montero, S. López-Tarruella, K. Pinilla, A. Casado, S. Fernandez, Y. Jerez, J. Puente, I. Palomero, R. González del Val, M. del Monte-Millan, T. Massarrah, C. Vila, B. García-Paredes, J. A. García-Sáenz, A. Lluch
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
Amanda E. D. Van Swearingen, Marni B. Siegel, Allison M. Deal, Maria J. Sambade, Alan Hoyle, D. Neil Hayes, Heejoon Jo, Paul Little, Elizabeth Claire Dees, Hyman Muss, Trevor Jolly, Timothy M. Zagar, Nirali Patel, C. Ryan Miller, Joel S. Parker, J. Keith Smith, Julie Fisher, Nikita Shah, Lisle Nabell, Rita Nanda, Patrick Dillon, Vandana Abramson, Lisa A. Carey, Carey K. Anders
Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
Dong-Yun Lee, Yeon Hee Park, Jeong Eon Lee, DooSeok Choi
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
Yihan Sun, Jae Hyun Kim, Kiran Vangipuram, Daniel F. Hayes, Ellen M. L. Smith, Larisa Yeomans, N. Lynn Henry, Kathleen A. Stringer, Daniel L. Hertz
Availability of prior mammograms affects incomplete report rates in mobile screening mammography
Marilyn A. Roubidoux, Peggy Shih-Pei Wu, Emily L. Roen Nolte, Joel A. Begay, Annette I. Joe
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03
Yasuaki Sagara, Masahiro Takada, Yasuyo Ohi, Shoichiro Ohtani, Sasagu Kurozumi, Kenichi Inoue, Yoshimasa Kosaka, Masaya Hattori, Toshinari Yamashita, Shintaro Takao, Nobuaki Sato, Hiroji Iwata, Masafumi Kurosumi, Masakazu Toi
Extremely brief mindfulness interventions for women undergoing breast biopsies: a randomized controlled trial
Bertha Andrade Coelho, Sara de Pinho Cunha Paiva, Agnaldo Lopes da Silva Filho
Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED)
Rosa Luraschi, Roberta Lazzari, Viviana Galimberti, Elena Rondi, Alessia Bazani, Giovanni Corso, Nicola Colombo, Rosalinda Ricotti, Cristiana Fodor, Mikolaj Winnicki, Maria Cristina Leonardi, Barbara Alicja Jereczek-Fossa, Federica Cattani
CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy
Laura E. Jansen, Wendy A. Teft, Rhiannon V. Rose, Daniel J. Lizotte, Richard B. Kim
Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study
K. J. Jerzak, J. G. Cockburn, S. K. Dhesy-Thind, G. R. Pond, K. I. Pritchard, S. Nofech-Mozes, P. Sun, S. A. Narod, A. Bane
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype
Yoon-Sim Yap, Prabhakaran Munusamy, Cindy Lim, Claire H. T. Chan, Aldo Prawira, Sau-Yeen Loke, Swee-Ho Lim, Kong-Wee Ong, Wei-Sean Yong, Sarah B. H. Ng, Iain B. H. Tan, David F. Callen, Jeffrey C. T. Lim, Aye-Aye Thike, Puay-Hoon Tan, Ann S. G. Lee
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
Ji-Yeon Kim, Ji Eun Lim, Hae Hyun Jung, Soo Youn Cho, Eun Yoon Cho, Se Kyung Lee, Jong Han Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer
Meghan Brennan, Paul Gass, Lothar Häberle, Daidong Wang, Arndt Hartmann, Michael P. Lux, Matthias W. Beckmann, Michael Untch, Peter A. Fasching
Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women
Julie S. Bedi, Rachel M. Mayo, Khoa Truong, Liwei Chen, Lori Dickes, Windsor W. Sherrill, Karyn Jones
Screening mammography: benefit of double reading by breast density
My von Euler-Chelpin, Martin Lillholm, George Napolitano, Ilse Vejborg, Mads Nielsen, Elsebeth Lynge
Estrogen-receptor status and risk of contralateral breast cancer following DCIS
Natasha K. Stout, Angel M. Cronin, Hajime Uno, Elissa M. Ozanne, Michael J. Hassett, Elizabeth S. Frank, Caprice C. Greenberg, Rinaa S. Punglia